Trial Search Results

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

University of Wisconsin, Madison

Collaborator: University of Texas

Stanford Investigator(s):

Intervention(s):

  • Other: MRI

Eligibility


Inclusion Criteria:

   - know or suspected iron overload

Exclusion Criteria:

   - contraindication to magnetic resonance imaging

Ages Eligible for Study

10 Years - 89 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Elisabeth Merkel, RN
650-736-0644
Recruiting